Elon Boms
Managing Director @ PV Capital Management
Boston, United States
Elon Boms is a Series C investor at PV Capital Management in Boston focused on Health Care and Biotechnology. Elon Boms is the Managing Director of Pritzker Vlock Capital Management. He previously worked at Thimble Point as a Chief Executive Officer. Elon Boms attended Yale School of Management.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Elon Boms invests in
Stages Elon Boms invests in
Countries Elon Boms invests in
Investment Focus
Industry
- Health Care 2 (40%)
- Biotechnology 2 (40%)
- Sports 1 (20%)
- Content 1 (20%)
- Medical 1 (20%)
Stage
- Series C 2 (40%)
- Funding Round 2 (40%)
- Series A 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Biorez
|
Biorez is a medical device company whose aim is to apply its patented and proprietary technology comprised of PLLA, a degradable polymer, in orthopedic implant devices for regeneration and augmentation of soft tissue. In addition to the L-C Ligament®, Biorez has also developed a suite of associated products, including the biorez GRAFT™, a FDA510(k)-cleared innovative device for soft tissue augmentation of the rotator cuff in the United States. | $1.5M / Series C / Mar 05, 2018 | |
Lumicell
|
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, iscurrently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.Lumicell was founded in 2008 and is based in Newton, MA, USA. | $28.7M / Series C / Oct 24, 2017 | |
|
Biorez
|
Biorez is a medical device company whose aim is to apply its patented and proprietary technology comprised of PLLA, a degradable polymer, in orthopedic implant devices for regeneration and augmentation of soft tissue. In addition to the L-C Ligament®, Biorez has also developed a suite of associated products, including the biorez GRAFT™, a FDA510(k)-cleared innovative device for soft tissue augmentation of the rotator cuff in the United States. | Jan 06, 2014 | |
Domino
|
Meet Domino, a Guide to Living with Style | Oct 03, 2013 | |
|
Domino
|
Meet Domino, a Guide to Living with Style | $5M / Series A / May 20, 2013 |
Co-Investors
About PV Capital Management
PV Capital Management manages a diverse and international asset base that includes companies innovating in biotech and medical technology, consumer and business software
PV Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jason Gray
Head of Investment Team
|
|||
|
Elon Boms
Managing Director
|
|||
Karen Pritzker
Founder
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Elon Boms invest in?
Elon Boms invests primarily in Health Care, Biotechnology and Sports startups, most often at Series C and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Elon Boms last invest?
The most recent investment recorded for Elon Boms closed in Mar 2018. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
